journal article·2026-05Open access

Perfusion Bioreactor Culture Incorporating Mechanical Confinement Enhances Mesenchymal Stem Cell Extracellular Vesicle Production and Wound Healing Potential

Emily H. Powsner, Raith Nowak, Stephanie M. Kronstadt, Nicholas H. Pirolli, Talia J. Solomon, Kristin Nikolov, William Pieper Holeman, Ian M. Smith, Kimberly M. Stroka, John P. Fisher, Steven M. Jay

Advanced Materials Technologies· Volume 11· Issue 10

Abstract

ABSTRACT Mesenchymal stem cell extracellular vesicles (MSC EVs) have been widely studied for regenerative medicine and tissue repair applications. However, clinical translation of EV therapeutics has been hampered by low potency and a lack of scalable production strategies. This work aims to develop a novel approach that exploits the mechanosensitivity of MSCs to enhance EV potency in the context of enhanced production via bioreactor culture. MSCs are well known to respond to mechanical stimuli such as substrate stiffness and shear stress, and here it is shown that exposing MSCs to another mechanoregulatory parameter, confinement, enhances the pro‐angiogenic bioactivity of their EVs. This is consistent across both donor‐derived primary MSCs and induced pluripotent stem cell‐derived MSCs (iMSCs). The development of a 3D‐printed perfusion bioreactor system that enables culture of confined MSCs under flow is also detailed here, resulting in a 67‐fold increase in EV production compared to flask culture. iMSC EVs obtained downstream of this confinement‐bioreactor culture induce greater vascularization and generally improve wound healing in a diabetic mouse model compared to iMSC EVs from conventional tissue culture. Overall, this work establishes the development of a scalable, bioreactor‐based iMSC EV production platform that provides a solution to major translational bottlenecks of therapeutic EVs.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Extracellular vesicles in disease · Mesenchymal stem cell research · Tissue Engineering and Regenerative Medicine

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Fischell Department of Bioengineering University of Maryland College Park Maryland USA

Robert E. Fischell Institute For Biomedical Devices University of Maryland College Park Maryland USA

Center for Engineering Complex Tissues University of Maryland College Park Maryland USA

Biophysics Program University of Maryland College Park Maryland USA

Center For Stem Cell Biology and Regenerative Medicine University of Maryland Baltimore Maryland USA

Marlene and Stewart Greenebaum Comprehensive Cancer Center University of Maryland Medical Center Baltimore Maryland USA

Program in Molecular and Cell Biology University of Maryland College Park Maryland USA

Funding

Maryland Department of Health · Maryland Stem Cell Research Fund · National Science Foundation · NIH Blueprint for Neuroscience Research

References (64)

Show source-provided references
1. 10.3390/cells807072710.3390/cells8070727 ↗
2. 10.3389/fcell.2021.70567610.3389/fcell.2021.705676 ↗
3. 10.1089/scd.2014.031610.1089/scd.2014.0316 ↗
4. 10.3390/cells808088610.3390/cells8080886 ↗
5. 10.1002/jev2.1251010.1002/jev2.12510 ↗
6. 10.3389/fbioe.2020.0099710.3389/fbioe.2020.00997 ↗
7. 10.3389/fcell.2021.73472010.3389/fcell.2021.734720 ↗
8. 10.1002/adhm.20230058410.1002/adhm.202300584 ↗
9. 10.1002/btm2.1006510.1002/btm2.10065 ↗
10. 10.3390/ijms2401088110.3390/ijms24010881 ↗
11. 10.1002/adhm.20200207010.1002/adhm.202002070 ↗
12. 10.1016/j.jconrel.2015.03.03310.1016/j.jconrel.2015.03.033 ↗
13. 10.3402/jev.v5.3253810.3402/jev.v5.32538 ↗
14. 10.1002/smll.20230176310.1002/smll.202301763 ↗
15. 10.3389/fphys.2020.0036510.3389/fphys.2020.00365 ↗
16. 10.1007/s13206‐010‐4311‐910.1007/s13206‐010‐4311‐9 ↗
17. 10.1038/s41368‐022‐00165‐510.1038/s41368‐022‐00165‐5 ↗
18. 10.1002/btm2.1074310.1002/btm2.10743 ↗
19. 10.1186/s12951‐025‐03556‐y10.1186/s12951‐025‐03556‐y ↗
20. 10.1038/aps.2009.4010.1038/aps.2009.40 ↗
21. 10.1016/j.celrep.2024.11469210.1016/j.celrep.2024.114692 ↗
22. 10.1016/j.cell.2014.02.05210.1016/j.cell.2014.02.052 ↗
23. 10.1021/acs.nanolett.8b0472010.1021/acs.nanolett.8b04720 ↗
24. 10.1038/s41563‐018‐0190‐610.1038/s41563‐018‐0190‐6 ↗
25. 10.1016/j.mtbio.2024.10130410.1016/j.mtbio.2024.101304 ↗
26. 10.1073/pnas.130888711010.1073/pnas.1308887110 ↗
27. 10.1002/adhm.20230082310.1002/adhm.202300823 ↗
28. 10.1002/cm.2143310.1002/cm.21433 ↗
29. 10.1073/pnas.161793311410.1073/pnas.1617933114 ↗
30. 10.1089/ten.tec.2019.008310.1089/ten.tec.2019.0083 ↗
31. 10.1016/j.cmet.2019.07.01110.1016/j.cmet.2019.07.011 ↗
32. 10.1186/s13287‐020‐01737‐010.1186/s13287‐020‐01737‐0 ↗
33. MicroRNA‐98‐5p Inhibits Proliferation and Metastasis in Non‐small Cell Lung Cancer by Targeting TGFBR1
34. 10.1155/2018/329037210.1155/2018/3290372 ↗
35. 10.1111/jcmm.1619210.1111/jcmm.16192 ↗
36. 10.1016/j.tcb.2020.09.00910.1016/j.tcb.2020.09.009 ↗
37. 10.3389/fcell.2021.73495010.3389/fcell.2021.734950 ↗
38. 10.1186/s12964‐021‐00730‐110.1186/s12964‐021‐00730‐1 ↗
39. 10.1038/s41596‐019‐0128‐810.1038/s41596‐019‐0128‐8 ↗
40. 10.1007/978-1-60761-175-2_710.1007/978-1-60761-175-2_7 ↗
41. 10.1002/pro.421810.1002/pro.4218 ↗
42. 10.3402/jev.v2i0.1986110.3402/jev.v2i0.19861 ↗
43. 10.1002/bit.2837810.1002/bit.28378 ↗
44. 10.1016/j.actbio.2018.11.02410.1016/j.actbio.2018.11.024 ↗
45. 10.1038/s41580‐023‐00576‐010.1038/s41580‐023‐00576‐0 ↗
46. 10.1039/D4NR01215A10.1039/D4NR01215A ↗
47. 10.1098/rsob.20022310.1098/rsob.200223 ↗
48. 10.1093/burnst/tkad02010.1093/burnst/tkad020 ↗
49. 10.1016/S0002‐9440(10)63821‐710.1016/S0002‐9440(10)63821‐7 ↗
50. 10.3389/fbioe.2022.95838110.3389/fbioe.2022.958381 ↗
51. 10.3390/ijms2504217210.3390/ijms25042172 ↗
52. 10.1038/sj.jid.570078610.1038/sj.jid.5700786 ↗
53. 10.1002/adhm.20230087910.1002/adhm.202300879 ↗
54. 10.3389/fbioe.2023.112918710.3389/fbioe.2023.1129187 ↗
55. 10.1016/j.biopha.2021.11194610.1016/j.biopha.2021.111946 ↗
56. 10.1007/s00403‐025‐03883‐y10.1007/s00403‐025‐03883‐y ↗
57. 10.1016/j.bioactmat.2023.04.01910.1016/j.bioactmat.2023.04.019 ↗
58. 10.1186/s13287‐021‐02333‐610.1186/s13287‐021‐02333‐6 ↗
59. 10.1111/jcmm.1569210.1111/jcmm.15692 ↗
60. 10.1038/srep1331610.1038/srep13316 ↗
61. 10.1016/j.ijbiomac.2025.14399510.1016/j.ijbiomac.2025.143995 ↗
62. 10.1152/ajpheart.00153.201510.1152/ajpheart.00153.2015 ↗
63. 10.1038/s41598‐018‐31441‐210.1038/s41598‐018‐31441‐2 ↗
64. 10.1016/j.chroma.2014.10.02610.1016/j.chroma.2014.10.026 ↗